4534 — Mochida Pharmaceutical Co Share Price
0.000.00%
Last trade - 00:00- ¥106bn
- ¥53bn
- ¥103bn
- 78
- 60
- 80
- 87
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.59 | ||
| PEG Ratio (f) | 1.47 | ||
| EPS Growth (f) | 12.7% | ||
| Dividend Yield (f) | 2.58% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.82 | ||
| Price to Tang. Book | 0.82 | ||
| Price to Free Cashflow | 20.34 | ||
| Price to Sales | 1.01 | ||
| EV to EBITDA | 5.4 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.12% | ||
| Return on Equity | 4.43% | ||
| Operating Margin | 6.57% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ¥m | 101,799 | 102,995 | 110,179 | 103,261 | 102,885 | 106,000 | 108,000 | -1.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -16.07 | +33.47 | +27.22 | -38.3 | -25.91 | +24.73 | +12.7 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
Directors
- Naoyuki Mochida PRE (62)
- Chu Sakata EVP (61)
- Keiichi Sagisaka SME (64)
- Junichi Sakaki SME (60)
- Kiyoshi Mizuguchi MEO (63)
- Kazumasa Fukuchi DSL
- Yoshitaka Hosaka DSL
- Kenji Miyajima DSL
- Junichi Makino DHR
- Yoshiharu Hashimoto EXO (58)
- Yutaka Kawakami EXO (61)
- Masayoshi Takeda EXO
- Taiji Hayano EXO
- Tomokazu Matsusue EXO
- Hitoshi Mizuno EXO
- Takeshi Mochida EXO
- Reiko Nakano EXO
- Kazunari Nakao EXO
- Masaaki Naotsuka EXO
- Tomoo Kugisawa IND (66)
- Nana Otsuki IND (56)
- Hirokuni Sogawa IND (78)
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 28th, 1945
- Public Since
- May 13th, 1963
- No. of Shareholders
- 6,218
- No. of Employees
- 1,522
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- Tokyo Stock Exchange
- Shares in Issue
- 34,371,055
- Address
- 1-7, Yotsuya, SHINJUKU-KU, 160-8515
- Web
- https://www.mochida.co.jp/
- Phone
- +81 333587211
- Auditors
- Ernst & Young ShinNihon LLC
Upcoming Events for 4534
Mochida Pharmaceutical Co Ltd Annual Shareholders Meeting
Q1 2026 Mochida Pharmaceutical Co Ltd Earnings Release
Similar to 4534
ASKA Pharmaceutical Holdings Co
Tokyo Stock Exchange
Astellas Pharma
Tokyo Stock Exchange
Astena Holdings Co
Tokyo Stock Exchange
CanBas Co
Tokyo Stock Exchange
CellSeed
Tokyo Stock Exchange
FAQ
What is the Mochida Pharmaceutical Co share price?
As of Today at 22:06 UTC, shares in Mochida Pharmaceutical Co are trading at ¥3,105. This share price information is delayed by 15 minutes.
How has the Mochida Pharmaceutical Co share price performed this year?
Shares in Mochida Pharmaceutical Co last closed at ¥3,105 and the price had moved by -0.32% over the past 365 days. In terms of relative price strength the Mochida Pharmaceutical Co share price has outperformed the Nikkei 225 Index by +5.05% over the past year.
What are the analyst and broker recommendations for Mochida Pharmaceutical Co?
The overall consensus recommendation for Mochida Pharmaceutical Co is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Mochida Pharmaceutical Co dividend yield?
The Mochida Pharmaceutical Co dividend yield is 2.58% based on the trailing twelve month period.
Does Mochida Pharmaceutical Co pay a dividend?
Last year, Mochida Pharmaceutical Co paid a total dividend of ¥80, and it currently has a trailing dividend yield of 2.58%.Looking ahead, the next dividend pay date is 2025-06-01.
When does Mochida Pharmaceutical Co next pay dividends?
We do not have data on when Mochida Pharmaceutical Co is to next pay dividends. The historic dividend yield on Mochida Pharmaceutical Co shares is currently 2.58%.
How do I buy Mochida Pharmaceutical Co shares?
To buy shares in Mochida Pharmaceutical Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Mochida Pharmaceutical Co?
As of the previous close price of ¥3,105, shares in Mochida Pharmaceutical Co had a market capitalisation of ¥106bn.
Where are Mochida Pharmaceutical Co shares listed?
Here are the trading details for Mochida Pharmaceutical Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 4534
What kind of share is Mochida Pharmaceutical Co?
Based on an overall assessment of its quality, value and momentum Mochida Pharmaceutical Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Mochida Pharmaceutical Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Mochida Pharmaceutical Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Mochida Pharmaceutical Co. Over the past six months, its share price has underperformed the Nikkei 225 Index by -0.23%.
As of the last closing price of ¥3,105, shares in Mochida Pharmaceutical Co were trading -6.28% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Mochida Pharmaceutical Co PE Ratio?
The Mochida Pharmaceutical Co PE ratio based on its reported earnings over the past 12 months is 16.59. The shares last closed at ¥3,105.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Mochida Pharmaceutical Co?
Mochida Pharmaceutical Co's management team is headed by:
- Naoyuki Mochida - PRE
- Chu Sakata - EVP
- Keiichi Sagisaka - SME
- Junichi Sakaki - SME
- Kiyoshi Mizuguchi - MEO
- Kazumasa Fukuchi - DSL
- Yoshitaka Hosaka - DSL
- Kenji Miyajima - DSL
- Junichi Makino - DHR
- Yoshiharu Hashimoto - EXO
- Yutaka Kawakami - EXO
- Masayoshi Takeda - EXO
- Taiji Hayano - EXO
- Tomokazu Matsusue - EXO
- Hitoshi Mizuno - EXO
- Takeshi Mochida - EXO
- Reiko Nakano - EXO
- Kazunari Nakao - EXO
- Masaaki Naotsuka - EXO
- Tomoo Kugisawa - IND
- Nana Otsuki - IND
- Hirokuni Sogawa - IND